Programmed death ligand 1, also known as PD-L1, B7-H1 or CD274 is a member of the B7 family of immune proteins that regulate T cell activation. PD-L1 is a ligand for the immune checkpoint receptor PD-1 and is expressed on tumor and immune cells. Expression of PD-L1 is crucial for the regulation of autoimmune and anti-tumor immune responses. In the tumor microenvironment, the PD-1 receptor/PD-L1 interaction is co-opted to provide protection to tumor cells from immune destruction. The ligand-receptor interaction between PD-L1 and PD-1 is a key target of cancer immunotherapy. We offer B7-H1/PD-L1/CD274 Antibodies fully covered by our Guarantee+. Our B7-H1/PD-L1/CD274 Antibodies can be used in a variety of model species: Human, Mouse, Rat, Monkey. We offer multiple pre-conjugated B7-H1/PD-L1/CD274 Antibodies including Alexa Fluor®, Biotin, Dylight and PE formats. Our B7-H1/PD-L1/CD274 antibodies have been validated in multiple applications including ELISA, Flow, ICC/IF, IHC and Western Blot.
Alternate Names for B7-H1/PD-L1/CD274 Antibodies
anti-B7-H1/PD-L1/CD274 antibody, anti-CD274 antibody, anti-B7-H antibody, anti-B7-H1 antibody, anti-B7H1PDCD1L1 antibody, anti-CD274 antigenMGC142294 antibody, anti-CD274 molecule antibody, anti-PD-L1 antibody, anti-PD-L1B7 homolog 1 antibody, anti-PDCD1LG1MGC142296 antibody, anti-PDL1PDCD1 ligand 1 antibody, anti-programmed cell death 1 ligand 1 antibody, anti-Programmed death ligand 1 antibody
10 Results for "b7-h1-pd-l1-cd274" in Primary Antibodies